Dr. Reddy’s Labs launches Sildenafil tablets

M. Somasekhar Hyderabad | Updated on November 19, 2012

Dr. Reddy’s Laboratories today announced the launch of Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

This follows the Hyderabad-based pharma major getting approval from the United States Food & Drug Administration for its abbreviated new drug application.

The Revatio brand, a trademark of Prizer Inc., had US sales of approximately $338.67 million for the most recent 12 months ended September 30, 2012, according to IMS Health.

Dr. Reddy’s Sildenafil tablets in 20 mg are available in 90 count bottle sizes.

Published on November 19, 2012

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like